JP2013147469A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013147469A5 JP2013147469A5 JP2012010336A JP2012010336A JP2013147469A5 JP 2013147469 A5 JP2013147469 A5 JP 2013147469A5 JP 2012010336 A JP2012010336 A JP 2012010336A JP 2012010336 A JP2012010336 A JP 2012010336A JP 2013147469 A5 JP2013147469 A5 JP 2013147469A5
- Authority
- JP
- Japan
- Prior art keywords
- intestinal
- butyric acid
- producing
- bacterium
- increasing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 33
- 241000894006 Bacteria Species 0.000 claims 19
- 230000000968 intestinal effect Effects 0.000 claims 18
- 239000003795 chemical substances by application Substances 0.000 claims 14
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 9
- 235000013305 food Nutrition 0.000 claims 6
- 244000063299 Bacillus subtilis Species 0.000 claims 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 241000186569 [Clostridium] leptum Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003674 animal food additive Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 210000002429 large intestine Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012010336A JP5921894B2 (ja) | 2012-01-20 | 2012-01-20 | 腸内酪酸産生菌増加剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012010336A JP5921894B2 (ja) | 2012-01-20 | 2012-01-20 | 腸内酪酸産生菌増加剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013147469A JP2013147469A (ja) | 2013-08-01 |
| JP2013147469A5 true JP2013147469A5 (enExample) | 2014-09-18 |
| JP5921894B2 JP5921894B2 (ja) | 2016-05-24 |
Family
ID=49045346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012010336A Active JP5921894B2 (ja) | 2012-01-20 | 2012-01-20 | 腸内酪酸産生菌増加剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5921894B2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015039305A (ja) * | 2013-08-20 | 2015-03-02 | 日清ペットフード株式会社 | ペットフード |
| US20160158174A1 (en) * | 2014-12-09 | 2016-06-09 | Intercontinental Great Brands Llc | Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients |
| TW201636010A (zh) * | 2014-12-26 | 2016-10-16 | Meiji Co Ltd | 有機酸的產生促進劑、發炎性腸疾病的預防及／或改善劑 |
| KR20180122380A (ko) * | 2016-03-14 | 2018-11-12 | 붓산 푸드사이언스 가부시키가이샤 | 피칼리박테리움속 세균증식제 |
| WO2017159643A1 (ja) * | 2016-03-14 | 2017-09-21 | 物産フードサイエンス株式会社 | 腸内酪酸増加剤および酪酸産生菌増殖剤 |
| JP7031662B2 (ja) * | 2017-03-28 | 2022-03-08 | 味の素株式会社 | 腸内環境改善用食品 |
| KR102282490B1 (ko) * | 2018-01-12 | 2021-07-28 | 주식회사 엠디헬스케어 | 패칼리박테리움 프라우스니찌 유래 나노소포 및 이의 용도 |
| WO2019191694A1 (en) * | 2018-03-29 | 2019-10-03 | Seres Therapeutics, Inc. | Compositions and methods for treating inflammatory bowel diseases |
| US20220288103A1 (en) * | 2018-08-29 | 2022-09-15 | Dsm Ip Assets B.V. | Formulations for improving gut health |
| CN113039196B (zh) | 2018-10-31 | 2025-03-18 | 株式会社村田制作所 | 抗革兰氏阴性菌化合物 |
| JP7508743B2 (ja) * | 2020-02-13 | 2024-07-02 | 池田食研株式会社 | 分泌型ＩｇＡ放出促進剤 |
| MX2023007685A (es) * | 2020-12-25 | 2023-11-22 | Hayashibara Co | Método para mejorar la productividad en ganado y aves de corral y método para mejorar la flora intestinal en ganado y/o aves de corral. |
| CN113930380B (zh) * | 2021-08-25 | 2024-03-26 | 武汉益鼎天养生物科技有限公司 | 一种促进栖粪杆菌增殖的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2528055B2 (ja) * | 1991-10-04 | 1996-08-28 | カルピス食品工業株式会社 | 鳥類飼料添加用腸内サルモネラ属細菌減少剤及びその使用法 |
| JP3028214B2 (ja) * | 1997-06-03 | 2000-04-04 | カルピス株式会社 | 鳥類用生菌剤の投与方法 |
| DE69929321T2 (de) * | 1998-04-01 | 2006-09-14 | Ganeden Biotech, Inc., San Diego | Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen |
| JP2008005702A (ja) * | 2004-12-06 | 2008-01-17 | Excel Japan Co Ltd | バチルス・マクロイデス菌、及びそれを利用した食品 |
| JP5199884B2 (ja) * | 2006-12-06 | 2013-05-15 | カルピス株式会社 | 炎症性腸疾患予防治療剤 |
| JP5836928B2 (ja) * | 2010-03-12 | 2015-12-24 | カルピス株式会社 | 大腸におけるビフィズス菌の増加及び減少抑制剤 |
| TW201136528A (en) * | 2010-03-17 | 2011-11-01 | Calpis Co Ltd | Agent for improving feed utilization efficiency of ruminant |
-
2012
- 2012-01-20 JP JP2012010336A patent/JP5921894B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013147469A5 (enExample) | ||
| Dalal et al. | Gut microbiota-derived metabolites in CRC progression and causation | |
| Pascal et al. | Microbiome and allergic diseases | |
| Walter et al. | Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm | |
| US12257272B2 (en) | Method and system for reducing the likelihood of developing depression in an individual | |
| Wei et al. | Gut microbiota: a new strategy to study the mechanism of electroacupuncture and moxibustion in treating ulcerative colitis | |
| ES2960781T3 (es) | Uso de comunidades microbianas para la salud humana y animal | |
| US20150265661A1 (en) | Prebiotic effect of sialyllactose | |
| Mikkelsen et al. | Effect of fructo-oligosaccharides and transgalacto-oligosaccharides on microbial populations and microbial activity in the gastrointestinal tract of piglets post-weaning | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| JP2016529309A5 (enExample) | ||
| US20240024382A1 (en) | Method and System to Modify an Individual's Gut-Brain Axis to Provide Neurocognitive Protection | |
| JP2019508486A5 (enExample) | ||
| PH12014501254A1 (en) | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof | |
| Zhou et al. | Salecan diet increases short chain fatty acids and enriches beneficial microbiota in the mouse cecum | |
| US11969445B2 (en) | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH | |
| Hoyles et al. | Gastrointestinal tract: intestinal fatty acid metabolism and implications for health | |
| Li et al. | Macleaya cordata helps improve the growth-promoting effect of chlortetracycline on broiler chickens | |
| US20240285697A1 (en) | Method and System to Modify an Individual’s Gut-Brain Axis to Provide Neurocognitive Protection | |
| Nemcová et al. | The effect of supplementation of flax-seed oil on interaction of Lactobacillus plantarum–Biocenol™ LP96 and Escherichia coli O8: K88ab: H9 in the gut of germ-free piglets | |
| Pieper et al. | Effect of Lactobacillus plantarum on intestinal microbial community composition and response to enterotoxigenic Escherichia coli challenge in weaning piglets | |
| MX338684B (es) | Prevencion y tratamiento de infeccion gastrointestinal en mamiferos. | |
| JP2016508368A5 (enExample) | ||
| Apata | The emergence of antibiotics resistance and utilization of probiotics for poultry production | |
| JP2010006801A5 (enExample) |